Sign Out
Pregnancy: For fosfomycin, no clinical data on pregnancies are available. Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonal/foetal development, parturition or postnatal development (see Pharmacology: Toxicology: Preclinical Safety data under Actions).
Fosfomycin should therefore not be prescribed to pregnant women unless the benefit outweighs the risk.
Lactation: After the administration of fosfomycin, low quantities of fosfomycin were found in human milk. Fosfomycin should therefore not be administered during lactation, unless the benefit outweighs the risk.
Continue with Google